CC BY-NC-ND 4.0 · Thromb Haemost 2024; 124(07): 656-668
DOI: 10.1055/s-0044-1782182
Blood Cells, Inflammation and Infection

Endothelial LAT1 (SLC7A5) Mediates S-Nitrosothiol Import and Modulates Respiratory Sequelae of Red Blood Cell Transfusion In Vivo

Hongmei Zhu
1   Department of Medicine, Duke University Medical Center, Durham, North Carolina, United States
2   Durham VA Health Care System, Durham North Carolina, United States
,
Richard L. Auten
3   Department of Pediatrics, Duke University Medical Center, Durham, North Carolina, United States
,
Augustus Richard Whorton
4   Department of Pharmacology, Duke University Medical Center, Durham, North Carolina, United States
,
Stanley Nicholas Mason
3   Department of Pediatrics, Duke University Medical Center, Durham, North Carolina, United States
,
Cheryl B. Bock
5   Rodent Cancer Models Shared Resource, Duke University Medical Center, Durham, North Carolina, United States
,
Gary T. Kucera
5   Rodent Cancer Models Shared Resource, Duke University Medical Center, Durham, North Carolina, United States
,
Zachary T. Kelleher
1   Department of Medicine, Duke University Medical Center, Durham, North Carolina, United States
,
Aaron T. Vose
1   Department of Medicine, Duke University Medical Center, Durham, North Carolina, United States
2   Durham VA Health Care System, Durham North Carolina, United States
,
1   Department of Medicine, Duke University Medical Center, Durham, North Carolina, United States
2   Durham VA Health Care System, Durham North Carolina, United States
› Author Affiliations
Funding Veterans Administration (BX-003478) and NIH (P30 CA-014236 and R01 HL-161071).


Abstract

Background Increased adhesivity of red blood cells (RBCs) to endothelial cells (ECs) may contribute to organ dysfunction in malaria, sickle cell disease, and diabetes. RBCs normally export nitric oxide (NO)-derived vascular signals, facilitating blood flow. S-nitrosothiols (SNOs) are thiol adducts formed in RBCs from precursor NO upon the oxygenation-linked allosteric transition in hemoglobin. RBCs export these vasoregulatory SNOs on demand, thereby regulating regional blood flow and preventing RBC–EC adhesion, and the large (system L) neutral amino acid transporter 1 (LAT1; SLC7A5) appears to mediate SNO export by RBCs.

Methods To determine the role of LAT1-mediated SNO import by ECs generally and of LAT1-mediated SNO import by ECs in RBC SNO-dependent modulation of RBC sequestration and blood oxygenation in vivo, we engineered LAT1fl/fl; Cdh5-Cre+ mice, in which the putative SNO transporter LAT1 can be inducibly depleted (knocked down, KD) specifically in ECs (“LAT1ECKD”).

Results We show that LAT1 in mouse lung ECs mediates cellular SNO uptake. ECs from LAT1ECKD mice (tamoxifen-induced LAT1fl/fl; Cdh5-Cre+) import SNOs poorly ex vivo compared with ECs from wild-type (tamoxifen-treated LAT1fl/fl; Cdh5-Cre) mice. In vivo, endothelial depletion of LAT1 increased RBC sequestration in the lung and decreased blood oxygenation after RBC transfusion.

Conclusion This is the first study showing a role for SNO transport by LAT1 in ECs in a genetic mouse model. We provide the first direct evidence for the coordination of RBC SNO export with EC SNO import via LAT1. SNO flux via LAT1 modulates RBC–EC sequestration in lungs after transfusion, and its disruption impairs blood oxygenation by the lung.

Supplementary Material



Publication History

Received: 15 March 2023

Accepted: 03 January 2024

Article published online:
22 March 2024

© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 McMahon TJ. Red blood cell deformability, vasoactive mediators, and adhesion. Front Physiol 2019; 10: 1417
  • 2 Bennett-Guerrero E, Veldman TH, Doctor A. et al. Evolution of adverse changes in stored RBCs. Proc Natl Acad Sci U S A 2007; 104 (43) 17063-17068
  • 3 Reynolds JD, Ahearn GS, Angelo M, Zhang J, Cobb F, Stamler JS. S-nitrosohemoglobin deficiency: a mechanism for loss of physiological activity in banked blood. Proc Natl Acad Sci U S A 2007; 104 (43) 17058-17062
  • 4 Zhu H, Zennadi R, Xu BX. et al. Impaired adenosine-5′-triphosphate release from red blood cells promotes their adhesion to endothelial cells: a mechanism of hypoxemia after transfusion. Crit Care Med 2011; 39 (11) 2478-2486
  • 5 Dosier LBM, Premkumar VJ, Zhu H, Akosman I, Wempe MF, McMahon TJ. Antagonists of the system L neutral amino acid transporter (LAT) promote endothelial adhesivity of human red blood cells. Thromb Haemost 2017; 117 (07) 1402-1411
  • 6 Turgeman A, McRae HL, Cahill C, Blumberg N, Refaai MA. Impact of RBC transfusion on peripheral capillary oxygen saturation and partial pressure of arterial oxygen. Am J Clin Pathol 2021; 156 (01) 149-154
  • 7 Reynolds JD, Bennett KM, Cina AJ. et al. S-nitrosylation therapy to improve oxygen delivery of banked blood. Proc Natl Acad Sci U S A 2013; 110 (28) 11529-11534
  • 8 Vostal JG, Buehler PW, Gelderman MP. et al. Proceedings of the Food and Drug Administration's public workshop on new red blood cell product regulatory science 2016. Transfusion 2018; 58 (01) 255-266
  • 9 Zhang R, Hess DT, Qian Z. et al. Hemoglobin βCys93 is essential for cardiovascular function and integrated response to hypoxia. Proc Natl Acad Sci U S A 2015; 112 (20) 6425-6430
  • 10 Zhang R, Hess DT, Reynolds JD, Stamler JS. Hemoglobin S-nitrosylation plays an essential role in cardioprotection. J Clin Invest 2016; 126 (12) 4654-4658
  • 11 Li S, Whorton AR. Functional characterization of two S-nitroso-L-cysteine transporters, which mediate movement of NO equivalents into vascular cells. Am J Physiol Cell Physiol 2007; 292 (04) C1263-C1271
  • 12 Quan L, Ohgaki R, Hara S. et al. Amino acid transporter LAT1 in tumor-associated vascular endothelium promotes angiogenesis by regulating cell proliferation and VEGF-A-dependent mTORC1 activation. J Exp Clin Cancer Res 2020; 39 (01) 266
  • 13 Najumudeen AK, Ceteci F, Fey SK. et al; CRUK Rosetta Grand Challenge Consortium. The amino acid transporter SLC7A5 is required for efficient growth of KRAS-mutant colorectal cancer. Nat Genet 2021; 53 (01) 16-26
  • 14 Scalise M, Galluccio M, Console L, Pochini L, Indiveri C. The human SLC7A5 (LAT1): the intriguing histidine/large neutral amino acid transporter and its relevance to human health. Front Chem 2018; 6: 243
  • 15 Sinclair LV, Rolf J, Emslie E, Shi YB, Taylor PM, Cantrell DA. Control of amino-acid transport by antigen receptors coordinates the metabolic reprogramming essential for T cell differentiation. Nat Immunol 2013; 14 (05) 500-508
  • 16 Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci U S A 1991; 88 (11) 4651-4655
  • 17 Fox-Robichaud A, Payne D, Hasan SU. et al. Inhaled NO as a viable antiadhesive therapy for ischemia/reperfusion injury of distal microvascular beds. J Clin Invest 1998; 101 (11) 2497-2505
  • 18 McMahon TJ, Shan S, Riccio DA. et al. Nitric oxide loading reduces sickle red cell adhesion and vaso-occlusion in vivo. Blood Adv 2019; 3 (17) 2586-2597
  • 19 Boado RJ, Li JY, Nagaya M, Zhang C, Pardridge WM. Selective expression of the large neutral amino acid transporter at the blood-brain barrier. Proc Natl Acad Sci U S A 1999; 96 (21) 12079-12084
  • 20 Asor E, Stempler S, Avital A, Klein E, Ruppin E, Ben-Shachar D. The role of branched chain amino acid and tryptophan metabolism in rat's behavioral diversity: Intertwined peripheral and brain effects. Eur Neuropsychopharmacol 2015; 25 (10) 1695-1705
  • 21 Tărlungeanu DC, Deliu E, Dotter CP. et al. Impaired amino acid transport at the blood brain barrier is a cause of autism spectrum disorder. Cell 2016; 167 (06) 1481-1494.e18
  • 22 Ohtsuki S, Yamaguchi H, Kang Y-S, Hori S, Terasaki T. Reduction of L-type amino acid transporter 1 mRNA expression in brain capillaries in a mouse model of Parkinson's disease. Biol Pharm Bull 2010; 33 (07) 1250-1252
  • 23 Zhang Y, Hogg N. The mechanism of transmembrane S-nitrosothiol transport. Proc Natl Acad Sci U S A 2004; 101 (21) 7891-7896
  • 24 Li S, Whorton AR. Identification of stereoselective transporters for S-nitroso-L-cysteine: role of LAT1 and LAT2 in biological activity of S-nitrosothiols. J Biol Chem 2005; 280 (20) 20102-20110
  • 25 Gaston B, Smith L, Bosch J. et al. Voltage-gated potassium channel proteins and stereoselective S-nitroso-l-cysteine signaling. JCI Insight 2020; 5 (18) e134174
  • 26 Sörensen I, Adams RH, Gossler A. DLL1-mediated Notch activation regulates endothelial identity in mouse fetal arteries. Blood 2009; 113 (22) 5680-5688
  • 27 Liu P, Jenkins NA, Copeland NG. A highly efficient recombineering-based method for generating conditional knockout mutations. Genome Res 2003; 13 (03) 476-484
  • 28 George SH, Gertsenstein M, Vintersten K. et al. Developmental and adult phenotyping directly from mutant embryonic stem cells. Proc Natl Acad Sci U S A 2007; 104 (11) 4455-4460
  • 29 Poncet N, Mitchell FE, Ibrahim AF. et al. The catalytic subunit of the system L1 amino acid transporter (slc7a5) facilitates nutrient signalling in mouse skeletal muscle. PLoS One 2014; 9 (02) e89547
  • 30 Bao EL, Chystsiakova A, Brahmajothi MV. et al. Bronchopulmonary dysplasia impairs L-type amino acid transporter-1 expression in human and baboon lung. Pediatr Pulmonol 2016; 51 (10) 1048-1056
  • 31 Ibrahim YI, Ninnis JR, Hopper AO. et al. Inhaled nitric oxide therapy increases blood nitrite, nitrate, and s-nitrosohemoglobin concentrations in infants with pulmonary hypertension. J Pediatr 2012; 160 (02) 245-251
  • 32 McMahon TJ, Doctor A. Extrapulmonary effects of inhaled nitric oxide: role of reversible S-nitrosylation of erythrocytic hemoglobin. Proc Am Thorac Soc 2006; 3 (02) 153-160
  • 33 Liu T, Schroeder HJ, Wilson SM. et al. Local and systemic vasodilatory effects of low molecular weight S-nitrosothiols. Free Radic Biol Med 2016; 91: 215-223
  • 34 Granillo OM, Brahmajothi MV, Li S. et al. Pulmonary alveolar epithelial uptake of S-nitrosothiols is regulated by L-type amino acid transporter. Am J Physiol Lung Cell Mol Physiol 2008; 295 (01) L38-L43
  • 35 Broniowska KA, Zhang Y, Hogg N. Requirement of transmembrane transport for S-nitrosocysteine-dependent modification of intracellular thiols. J Biol Chem 2006; 281 (45) 33835-33841
  • 36 Reynolds JD, Posina K, Zhu L. et al. Control of tissue oxygenation by S-nitrosohemoglobin in human subjects. Proc Natl Acad Sci U S A 2023; 120 (09) e2220769120
  • 37 Tinmouth A, Fergusson D, Yee IC, Hébert PC. ABLE Investigators, Canadian Critical Care Trials Group. Clinical consequences of red cell storage in the critically ill. Transfusion 2006; 46 (11) 2014-2027
  • 38 Payne S, De Val S, Neal A. Endothelial-specific cre mouse models. Arterioscler Thromb Vasc Biol 2018; 38 (11) 2550-2561